Local lab gets green light to produce active ingredients derived from cannabis
GESlabs will export pharmaceutical ingredients to the UK, US, Israel and Australia where demand is high for the single molecule cannabinoids
18 January 2022 - 19:27
Pharmaceutical manufacturing company GESlabs has become one of Africa’s first cannabis dedicated, Good Manufacturing Practice (GMP) approved manufacturing laboratories licensed to export scheduled narcotic extracts.
After two years of negotiations and making safety improvements, the SA Health Products Regulatory Authority (Sahpra) has finally issued a licence to GESlabs to manufacture cannabinoid pharmaceutical ingredients for use in therapeutic medicines, the only company in Southern Africa with such a licence. ..
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.